1. Home
  2. AMCX vs BWAY Comparison

AMCX vs BWAY Comparison

Compare AMCX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

N/A

Current Price

$11.79

Market Cap

492.0M

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$13.59

Market Cap

578.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCX
BWAY
Founded
1980
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.0M
578.5M
IPO Year
2011
2011

Fundamental Metrics

Financial Performance
Metric
AMCX
BWAY
Price
$11.79
$13.59
Analyst Decision
Sell
Strong Buy
Analyst Count
4
2
Target Price
$7.33
$13.25
AVG Volume (30 Days)
452.4K
67.5K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
N/A
EPS
N/A
N/A
Revenue
$2,311,801,000.00
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
N/A
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$6.47
$11.77
52 Week High
$12.93
$26.63

Technical Indicators

Market Signals
Indicator
AMCX
BWAY
Relative Strength Index (RSI) 52.71 37.29
Support Level $9.23 $11.90
Resistance Level $12.72 $14.83
Average True Range (ATR) 0.42 0.44
MACD -0.10 -0.07
Stochastic Oscillator 60.00 24.55

Price Performance

Historical Comparison
AMCX
BWAY

About AMCX AMC Networks Inc.

AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: